Plastic antibody for DNA damage: fluorescent imaging of BPDE-dG adducts in genomic DNA

Junfa Yin1, Zhixin Wang, Maoyong Song

  • 1State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, 100085, China.

The Analyst
|July 3, 2013
PubMed

Insights

Researchers developed a novel plastic antibody (nanoMIP) for detecting DNA damage from carcinogens like benzo[a]pyrene diol epoxide (BPDE). This method enables ultrasensitive detection of BPDE-DNA adducts in cells.

Area of Science:

  • Biomaterials Science
  • Analytical Chemistry
  • Molecular Biology

Background:

  • Genotoxic carcinogens can cause DNA damage, leading to adverse health effects.
  • Detecting trace DNA damage in complex biological samples is challenging.
  • Existing antibody-based methods can be immunogenic and less versatile.

Purpose of the Study:

  • To develop a "plastic antibody" (nanoMIP) for specific recognition of benzo[a]pyrene diol epoxide (BPDE)-DNA adducts.
  • To create a highly sensitive immunoassay for detecting DNA damage.
  • To offer an alternative to traditional antibody-based assays for genomic analysis.

Main Methods:

  • Fabrication of molecularly imprinted polymer (MIP) nanocomposites (nanoMIPs) using initiators for continuous activator regeneration-atom transfer radical polymerization (ICAR-ATRP).
  • Development of a fluorescently imaged particle counting immunoassay (FIPCIA) utilizing nanoMIPs for capturing BPDE-DNA adducts.
  • Detection of BPDE-ssDNA adducts using laser scanning confocal microscopy (LSCM).

Main Results:

  • NanoMIPs demonstrated enhanced binding affinity (880 nM) for BPDE-DNA adducts.
  • The FIPCIA method achieved ultrasensitive detection of BPDE-ssDNA adducts down to 18 pM.
  • The number of fluorescent dots correlated directly with the concentration of BPDE-ssDNA adducts.

Conclusions:

  • The developed nanoMIP-based FIPCIA is a highly sensitive and specific method for detecting DNA damage.
  • This plastic antibody approach provides a promising alternative to immunogenic antibody-based immunoassays.
  • The method has potential applications in genomics and DNA modification analysis.